SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001019056-10-000970
Filing Date
2010-07-30
Accepted
2010-07-30 17:17:55
Documents
1
Group Members
APIS CAPITAL (QP), LPAPIS CAPITAL ADVISORS, LLCAPIS CAPITAL, LPAPIS GLOBAL DEEP VALUE OFFSHORE, LTD.APIS GLOBAL DEEP VALUE, LPAPIS OFFSHORE CAPITAL, LTD.DANIEL J. BARKER

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A biospecifics_13ga1.htm SC 13G/A 155046
  Complete submission text file 0001019056-10-000970.txt   157222
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79091 | Film No.: 10982032
SIC: 2834 Pharmaceutical Preparations

Mailing Address 53 FOREST AVENUE SUITE 103 OLD GREENWICH CT 06870
Business Address 53 FOREST AVENUE SUITE 103 OLD GREENWICH CT 06870 203-364-8809
APIS CAPITAL ADVISORS, LLC (Filed by) CIK: 0001386892 (see all company filings)

IRS No.: 200692626 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A